Richard Kaschula PhD | NG Bio

More insights

Investment

Abselion raises £6.6 million led by M Ventures

December 4, 2024

News

Martin Bloom joins NG Bio’s Board of Directors

November 25, 2024

Investment

LightOx raises £1.5m to develop oral cancer preventative treatment

June 13, 2024